A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40257-022-00674-3.pdf
Reference104 articles.
1. Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000;43:138–50. https://doi.org/10.1067/mjd.2000.107497.
2. Werner RN, Sammain A, Erdmann R, et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502–18. https://doi.org/10.1111/bjd.12420.
3. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 2006;155:9–22. https://doi.org/10.1111/j.1365-2133.2005.07121.x.
4. Feldman SR, Fleischer AB Jr. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis. 2011;87:201–7.
5. Ferrandiz C. Update on actinic keratosis in clinical trial experience with imiquimod. Br J Dermatol. 2007;157:32–3. https://doi.org/10.1111/j.1365-2133.2007.08270.x.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Painless photodynamic therapy for facial actinic keratoses: A retrospective cohort study of the post-treatment inflammatory response;Photodiagnosis and Photodynamic Therapy;2024-02
2. Full-face ALA-PDT for facial actinic keratosis: Two case reports;Photodiagnosis and Photodynamic Therapy;2024-02
3. Tirbanibulin 1% Ointment for Actinic Keratosis: Results from a Real-Life Study;Medicina;2024-01-28
4. Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis;Clinical Pharmacology in Drug Development;2024-01-07
5. Assessment of Some Unsymmetrical Porphyrins as Promising Molecules for Photodynamic Therapy of Cutaneous Disorders;Pharmaceuticals;2023-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3